AAV9-mediated overexpression of miR-1 reduced several markers of cardiac hypertrophy including MYH6 and blunted adverse cardiac remodeling through maintenance of calcium homeostasis regulation by sarco/endoplasmic reticulum Ca2+ (Serca) [105]. The gene discussed is MYH6; the disease is cardiac hypertrophy.